221S-1a inhibits endothelial proliferation in pathological angiogenesis through ERK/c-Myc signaling.

[1]  M. Ruan,et al.  Exploring the synergic mechanism of Ligusticum striatum DC. and borneol in attenuating BMECs injury and maintaining tight junctions against cerebral ischaemia based on the HIF-1α/VEGF signalling pathway. , 2022, Journal of ethnopharmacology.

[2]  Huijun Wu,et al.  Danshensu Enhances Cerebral Angiogenesis through PI3K/Akt/mTOR/VEGF Signaling Pathway in Mice. , 2022, CNS & neurological disorders drug targets.

[3]  Songyi Lin,et al.  Peptides derived from sea cucumber accelerate cells proliferation and migration for wound healing by promoting energy metabolism and upregulating the ERK/AKT pathway. , 2022, European journal of pharmacology.

[4]  Keyang Chen,et al.  Captopril alleviates oxidative damage in diabetic retinopathy. , 2021, Life sciences.

[5]  E. Duh,et al.  Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy , 2021, JCI insight.

[6]  M. Simons,et al.  Emerging roles of PLCγ1 in endothelial biology , 2021, Science Signaling.

[7]  C. Murray,et al.  ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK , 2021, Molecular Cancer Therapeutics.

[8]  H. Yin,et al.  Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis , 2021, Theranostics.

[9]  Chaoni Xiao,et al.  A novel compound DBZ ameliorates neuroinflammation in LPS-stimulated microglia and ischemic stroke rats: Role of Akt(Ser473)/GSK3β(Ser9)-mediated Nrf2 activation , 2020, Redox biology.

[10]  Jessica K. Gagnon,et al.  ERK signalling: a master regulator of cell behaviour, life and fate , 2020, Nature Reviews Molecular Cell Biology.

[11]  T. Muley,et al.  Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer. , 2020, Cancer cell.

[12]  Wei Zhang,et al.  ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials , 2020, Drugs.

[13]  Deepak L. Bhatt,et al.  Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association. , 2020, Circulation.

[14]  C. López-Camarillo,et al.  Contribution of Angiogenesis to Inflammation and Cancer , 2019, Front. Oncol..

[15]  P. Zhang,et al.  Tanshinol borneol ester, a novel synthetic small molecule angiogenesis stimulator inspired by botanical formulations for angina pectoris , 2019, British journal of pharmacology.

[16]  Jian Sun,et al.  Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis , 2019, Front. Pharmacol..

[17]  Asghar Fallah,et al.  Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  E. Parati,et al.  Human Olfactory Bulb Neural Stem Cells (Hu-OBNSCs) Can Be Loaded with Paclitaxel and Used to Inhibit Glioblastoma Cell Growth , 2019, Pharmaceutics.

[19]  S. Hill,et al.  Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2 , 2018, International journal of molecular sciences.

[20]  Emma Gordon,et al.  Mechanisms and regulation of endothelial VEGF receptor signalling , 2016, Nature Reviews Molecular Cell Biology.

[21]  Wun-Jae Kim,et al.  Esculetin Inhibits VEGF-Induced Angiogenesis Both In Vitro and In Vivo. , 2016, The American journal of Chinese medicine.

[22]  Yajun Bai,et al.  A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway , 2015, British journal of pharmacology.

[23]  D. Jeong,et al.  Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis , 2015, Annals of surgical treatment and research.

[24]  Javier León,et al.  Myc and cell cycle control. , 2015, Biochimica et biophysica acta.

[25]  M. Murakami,et al.  Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells. , 2015, Circulation research.

[26]  S. Knapp,et al.  A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics , 2014, Nature chemical biology.

[27]  Kristin Reiche,et al.  Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs , 2014, Genome Biology.

[28]  Thomas Efferth,et al.  Synergistic Inhibition of Angiogenesis by Artesunate and Captopril In Vitro and In Vivo , 2013, Evidence-based complementary and alternative medicine : eCAM.

[29]  D. Mukhopadhyay,et al.  NHERF-2 maintains endothelial homeostasis. , 2012, Blood.

[30]  G. Thurston,et al.  Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors , 2010, Cancer biology & therapy.

[31]  V. Pande,et al.  Network models for molecular kinetics and their initial applications to human health , 2010, Cell Research.

[32]  S. Meloche,et al.  Genetic Demonstration of a Redundant Role of Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Mitogen-Activated Protein Kinases in Promoting Fibroblast Proliferation , 2010, Molecular and Cellular Biology.

[33]  Z. Li,et al.  Influence of Borneol on In Vitro Corneal Permeability and on In Vivo and In Vitro Corneal Toxicity , 2009, The Journal of international medical research.

[34]  Chang Sik Cho,et al.  Blockade of Angiotensin II Attenuates VEGF-Mediated Blood—Retinal Barrier Breakdown in Diabetic Retinopathy , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  P. Collas,et al.  cAMP-mediated induction of cyclin E sensitizes growth-arrested adipose stem cells to DNA damage-induced apoptosis. , 2008, Molecular biology of the cell.

[36]  B. Bryan,et al.  What tangled webs they weave: Rho-GTPase control of angiogenesis , 2007, Cellular and Molecular Life Sciences.

[37]  J. Folkman.  Opinion: Angiogenesis: an organizing principle for drug discovery? , 2007, Nature Reviews Drug Discovery.

[38]  M. Shibuya,et al.  Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. D. de Waal,et al.  Anti‐tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model , 2004, International journal of cancer.

[40]  V. Sukhatme,et al.  In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril. , 2003, Journal of the National Cancer Institute.

[41]  O. Volpert,et al.  Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. , 1996, The Journal of clinical investigation.

[42]  E. Papadimitriou,et al.  In Vitro Spheroid Sprouting Assay of Angiogenesis. , 2019, Methods in molecular biology.

[43]  P. Richardson,et al.  A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. , 2014, Blood.